This page is part of the Adverse Event Clinical Research (v1.0.0-ballot: STU 1 Ballot 1) based on FHIR v5.0.0. . For a full list of available versions, see the Directory of published versions
Page standards status: Informative |
Generated Narrative: AdverseEvent
Resource AdverseEvent "adverse-event-compass-ex1a"
Profile: Adverse Event Clinical Research
Severity Or Grade: Severe (AdverseEvent Severity or Grade Codes#3)
status: in-progress
actuality: actual
code: Alanine aminotransferase (ALT) increased to 200 (www.meddra.org#10001551 "Alanine aminotransferase increased")
subject: Patient/patient-example-kaitlyn-b " BOUNCE"
occurrence: 2020-05-13 --> (ongoing)
seriousness: Non-serious (AdverseEventSeriousness#non-serious)
outcome: Not recovering/not resolved (NCI Thesaurus#C49494)
recorder: Practitioner/practitioner-oncology-nurse-jane " NURSE"
Function | Actor |
authenticator (ParticipationType#AUTHEN) | Practitioner/practitioner-owen-oncologist " ONCOLOGIST" |
study: ResearchStudy/clinical-trial-example-compass
expectedInResearchStudy: true
suspectEntity
instance: MedicationAdministration/medication-administration-kadcyla
Causalities
EntityRelatedness Possibly Related (NCI Thesaurus#C53258)
suspectEntity
instance: MedicationAdministration/medication-administration-tucatinib
Causalities
EntityRelatedness Possibly Related (NCI Thesaurus#C53258)
note: treatment held today per protocol guidelines and the patient was scheduled to return in one week for repeat lab work